Get Quote

Harvard Bioscience, Inc. (NASDAQ:HBIO)

CAPS Game Rating: 5 out of 5

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.

Recs

0
Member Avatar evilcliver (23.40) Submitted: 08/07/2011 18:04:42 : Outperform Start Price: $5.81 HBIO Score: -35.72

Harvard Bioscience's Bioreactor Grows a Synthetic Tissue-Engineered Trachea Used in World's First Successful Human Transplantation

This is huge news, the stuff of Science Fiction! This stock is golden if they can continue to offer more engineered organs.

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.